Vaccines
Worrisome new coronavirus variants can evade antibodies that neutralize original virus, recent lab research shows
| 4 min read
A research team suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible
| 2 min read
These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines
| 2 min read
Breakthroughs in vaccine development achieved in just 10 months show value of working together
| 2 min read
Panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples
| 1 min read
Government non-dilutive funding set the stage for the production of COVID-19 vaccines
| 4 min read
Scientists have developed a novel strategy that redirects antibodies for other diseases existing in humans to the spike proteins of SARS-CoV-2
| 2 min read
Antigens and antibodies for livestock and companion animal diseases to support development of diagnostics and vaccines
| 1 min read
